These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor. Sternfeld F; Guiblin AR; Jelley RA; Matassa VG; Reeve AJ; Hunt PA; Beer MS; Heald A; Stanton JA; Sohal B; Watt AP; Street LJ J Med Chem; 1999 Feb; 42(4):677-90. PubMed ID: 10052975 [TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis. Runfola M; Sestito S; Bellusci L; La Pietra V; D'Amore VM; Kowalik MA; Chiellini G; Gul S; Perra A; Columbano A; Marinelli L; Novellino E; Rapposelli S Eur J Med Chem; 2020 Feb; 188():112006. PubMed ID: 31931337 [TBL] [Abstract][Full Text] [Related]
27. Heterocyclic 1,7-disubstituted indole sulfonamides are potent and selective human EP3 receptor antagonists. Hategan G; Polozov AM; Zeller W; Cao H; Mishra RK; Kiselyov AS; Ramirez J; Halldorsdottir G; Andrésson T; Gurney ME; Singh J Bioorg Med Chem Lett; 2009 Dec; 19(23):6797-800. PubMed ID: 19836233 [TBL] [Abstract][Full Text] [Related]
28. 2-(1H-Pyrazol-1-yl)acetic acids as chemoattractant receptor-homologous molecule expressed on Th2 lymphocytes (CRTh2) antagonists. Andrés M; Bravo M; Buil MA; Calbet M; Castillo M; Castro J; Eichhorn P; Ferrer M; Lehner MD; Moreno I; Roberts RS; Sevilla S Eur J Med Chem; 2014 Jan; 71():168-84. PubMed ID: 24292338 [TBL] [Abstract][Full Text] [Related]
29. The thyroid hormone receptor-beta agonist GC-1 induces cell proliferation in rat liver and pancreas. Columbano A; Pibiri M; Deidda M; Cossu C; Scanlan TS; Chiellini G; Muntoni S; Ledda-Columbano GM Endocrinology; 2006 Jul; 147(7):3211-8. PubMed ID: 16574785 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and pharmacological evaluation of aminopyrimidine series of 5-HT1A partial agonists. Dounay AB; Barta NS; Bikker JA; Borosky SA; Campbell BM; Crawford T; Denny L; Evans LM; Gray DL; Lee P; Lenoir EA; Xu W Bioorg Med Chem Lett; 2009 Feb; 19(4):1159-63. PubMed ID: 19147349 [TBL] [Abstract][Full Text] [Related]
31. Characterisation of liver-specific distribution of a novel 1-benzyl-4-aminoindole-based thyroid hormone receptor β agonist, SKL-13784: comparison with GC-1. Takahashi N; Izuchi T Xenobiotica; 2016; 46(2):108-16. PubMed ID: 26075834 [TBL] [Abstract][Full Text] [Related]
32. Discovery of a Highly Selective and H435R-Sensitive Thyroid Hormone Receptor β Agonist. Li Q; Yao B; Zhao S; Lu Z; Zhang Y; Xiang Q; Wu X; Yu H; Zhang C; Li J; Zhuang X; Wu D; Li Y; Xu Y J Med Chem; 2022 May; 65(10):7193-7211. PubMed ID: 35507418 [TBL] [Abstract][Full Text] [Related]
33. Further studies on ethyl 5-hydroxy-indole-3-carboxylate scaffold: design, synthesis and evaluation of 2-phenylthiomethyl-indole derivatives as efficient inhibitors of human 5-lipoxygenase. Peduto A; Bruno F; Dehm F; Krauth V; de Caprariis P; Weinigel C; Barz D; Massa A; De Rosa M; Werz O; Filosa R Eur J Med Chem; 2014 Jun; 81():492-8. PubMed ID: 24871899 [TBL] [Abstract][Full Text] [Related]
35. Design and synthesis of novel 3-substituted-indole derivatives as selective H3 receptor antagonists and potent free radical scavengers. Tang L; Zhao L; Hong L; Yang F; Sheng R; Chen J; Shi Y; Zhou N; Hu Y Bioorg Med Chem; 2013 Oct; 21(19):5936-44. PubMed ID: 23978359 [TBL] [Abstract][Full Text] [Related]
36. Hormone selectivity in thyroid hormone receptors. Wagner RL; Huber BR; Shiau AK; Kelly A; Cunha Lima ST; Scanlan TS; Apriletti JW; Baxter JD; West BL; Fletterick RJ Mol Endocrinol; 2001 Mar; 15(3):398-410. PubMed ID: 11222741 [TBL] [Abstract][Full Text] [Related]
37. Structure-activity relationship of 5-chloro-2-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole analogues as 5-HT(6) receptor agonists. Mattsson C; Svensson P; Boettcher H; Sonesson C Eur J Med Chem; 2013 May; 63():578-88. PubMed ID: 23542166 [TBL] [Abstract][Full Text] [Related]
38. Methyl (11aS)-1,2,3,5,11,11a-hexahydro-3,3-dimethyl-1-oxo-6H-imidazo-[3',4':1,2]pyridin[3,4-b]indol-2-substituted acetates: synthesis and three-dimensional quantitative structure-activity relationship investigation as a class of novel vasodilators. Liu J; Zhao M; Cui G; Zhang X; Wang J; Peng S J Med Chem; 2008 Aug; 51(15):4715-23. PubMed ID: 18616237 [TBL] [Abstract][Full Text] [Related]
39. Structural basis for the structure-activity relationships of peroxisome proliferator-activated receptor agonists. Mahindroo N; Peng YH; Lin CH; Tan UK; Prakash E; Lien TW; Lu IL; Lee HJ; Hsu JT; Chen X; Liao CC; Lyu PC; Chao YS; Wu SY; Hsieh HP J Med Chem; 2006 Oct; 49(21):6421-4. PubMed ID: 17034149 [TBL] [Abstract][Full Text] [Related]
40. Design and synthesis of novel and potent amide linked PPARgamma/delta dual agonists. Shi Q; Canada EJ; Xu Y; Warshawsky AM; Etgen GJ; Broderick CL; Clutinger CK; Irwin LA; Laurila ME; Montrose-Rafizadeh C; Oldham BA; Wang M; Winneroski LL; Xie C; York JS; Yumibe NP; Zink RW; Mantlo N Bioorg Med Chem Lett; 2007 Dec; 17(24):6744-9. PubMed ID: 18029178 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]